ACURA PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/32fb3b80-94f1-4ace-93bc-2df15f80b790/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-1.2M | 2021-01-01 – 2021-12-31 | evidence 0001410578-23-001462 |
| FY 2020 | $-758.0k | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-044760 |
| FY 2019 | $-725.0k | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-040632 |
| FY 2018 | $-3.9M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-046746 |
| FY 2017 | $-5.2M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-061732 |
| FY 2016 | $-6.6M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-018146 |
| FY 2015 | $-4.0M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-085018 |
| FY 2014 | $-12.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-013292 |
| FY 2013 | $-14.1M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-012919 |
| FY 2012 | $-9.7M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-012648 |
| FY 2011 | $10.5M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-012928 |
| FY 2010 | $-12.7M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-012928 |
| FY 2009 | $-13.5M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-012928 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACURA PHARMACEUTICALS, INC. — all facts · Revenue · Net Income